• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

The analysis of the spindle checkpoint protens and the application to the new molecular targetted therapy for colorectal cancer.

Research Project

Project/Area Number 25462059
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Research Field Digestive surgery
Research InstitutionKyushu University

Principal Investigator

Emi Yasunori  九州大学, 医学(系)研究科(研究院), 研究員 (50223673)

Co-Investigator(Kenkyū-buntansha) MORITA Masaru  独立行政法人国立病院機構(九州がんセンター臨床研究センター), その他部局等, その他 (30294937)
KITAO Hiroyuki  九州大学, 医学研究院, 准教授 (30368617)
OKI Eiji  九州大学, 大学病院, 講師 (70380392)
SAEKI Hiroshi  九州大学, 医学研究院, 准教授 (80325448)
安藤 幸滋  九州大学, 大学病院, 助教 (20608864)
Project Period (FY) 2013-04-01 – 2016-03-31
Project Status Completed (Fiscal Year 2015)
Budget Amount *help
¥4,940,000 (Direct Cost: ¥3,800,000、Indirect Cost: ¥1,140,000)
Fiscal Year 2015: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2014: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Fiscal Year 2013: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
Keywords大腸癌 / ゲノム不安定性 / 細胞分裂期スピンドルチェックポイント機構 / p53 / MSI / BUBR1
Outline of Final Research Achievements

To elucidate the clinical significance of spindle checkpoint protein in colorectal cancer, and to find the new candidate for molecular targeted therapy, we analyzed the expression of the spindle checkpoint proteins in colorectal clinical samples. We investigated the interplay between BUBR1 and p53 and their association with genetic instability in colorectal cancer. In 139 colorectal cases, cases with high BUBR1 expression and TP53 mutation had profound aneuploidy phenotypes and less frequent MSI. On the other hand, high expression of PLK1 was also associated with DNA aneuploidy in clinical gastric cancer specimens. High expression of PLK1 could have detrimental effects in tumors with DNA aneuploidy. These findings indicate that spindle checkpoint proteins might contribute cooperatively to the DNA aneuploidy and the carcinogenesis.

Report

(3 results)
  • 2015 Annual Research Report   Final Research Report ( PDF )
  • 2013 Research-status Report
  • Research Products

    (12 results)

All 2014 2013 Other

All Journal Article (8 results) (of which Peer Reviewed: 8 results) Presentation (3 results) Remarks (1 results)

  • [Journal Article] Initial report of KSCC0803: feasibility study of capecitabine as adjuvant chemotherapy for stage III colon cancer in Japanese patients.2013

    • Author(s)
      Emi Y., Kakeji Y., Oki E., Saeki H., Ando K.,
    • Journal Title

      Int J Clin Oncol

      Volume: 18 Pages: 254-259

    • NAID

      10031176263

    • Related Report
      2013 Research-status Report
    • Peer Reviewed
  • [Journal Article] Newly Developed Liver-Retraction Method for Laparoscopic Gastric Surgery Using a Silicone Disc: the Φ-Shaped Technique.2013

    • Author(s)
      "Saeki H., Oki E., Kawano H., Ando K., Ida S.,
    • Journal Title

      Journal of the American College of Surgeons

      Volume: 216

    • Related Report
      2013 Research-status Report
    • Peer Reviewed
  • [Journal Article] Totally Laparoscopic Distal Gastrectomy for Elderly Patients with Gastric Cancer.2013

    • Author(s)
      Oki E., Sakaguchi Y., Ohgaki K., Saeki H., Ikegami T., Minami K., Yamashita Y., Toh Y., Soejima Y., Ando K., Mimori K., Watanabe M., Sugimachi K., Uchiyama H., Yoshizumi T., Kawanaka H., Morita M., Ikeda T., Maehara Y.
    • Journal Title

      Fukuoka Acta Medica

      Volume: 104 Pages: 290-298

    • NAID

      120005372094

    • Related Report
      2013 Research-status Report
    • Peer Reviewed
  • [Journal Article] Mortalin is a prognostic factor of gastric cancer with normal p53 function.2013

    • Author(s)
      Ando K., Oki E., Zhao Y., Yoshida A., Kitao H., Saeki H., Kimura Y., Ida S., Morita M., Kusumoto T., Maehara Y.
    • Journal Title

      Gastric Cancer

      Volume: 17 Pages: 255-262

    • NAID

      40020216055

    • Related Report
      2013 Research-status Report
    • Peer Reviewed
  • [Journal Article] Advances in esophageal surgery in elderly patients with thoracic esophageal cancer.2013

    • Author(s)
      "Morita M., Kawano H., Otsu H., Kimura K., Saeki H.,
    • Journal Title

      Anticancer Res

      Volume: 33 Pages: 1641-1647

    • Related Report
      2013 Research-status Report
    • Peer Reviewed
  • [Journal Article] Surgical resection for esophageal cancer synchronously or metachronously associated with head and neck cancer.2013

    • Author(s)
      "Morita M., Kawano H., Otsu H., Kimura K., Saeki H.,
    • Journal Title

      Ann Surg Oncol

      Volume: 20 Pages: 2434-2439

    • Related Report
      2013 Research-status Report
    • Peer Reviewed
  • [Journal Article] Esophageal replacement by colon interposition with microvascul.ar surgery for patients with thoracic esophageal cancer -the utility of superdrainage.2013

    • Author(s)
      Saeki H., Morita M., Harada N., Egashira A., Oki E., Uchiyama H., OhgaT., Kakeji Y., Sakaguchi Y., Maehara Y.
    • Journal Title

      Diseases of the Esophagus

      Volume: 26 Pages: 50-56

    • Related Report
      2013 Research-status Report
    • Peer Reviewed
  • [Journal Article] Multimodal treatment strategy for clinical T3 thoracic esophageal cancer.2013

    • Author(s)
      "Saeki H., Morita M., Tsuda Y., Hidaka G., Kasagi Y.,
    • Journal Title

      Annals of Surgical Oncology

      Volume: 20 Pages: 4267-4273

    • Related Report
      2013 Research-status Report
    • Peer Reviewed
  • [Presentation] Analysis of KRAS/NRAS, PI3CA and BRAF mutations in the phase 2 KSCC0901 study of cetuximab + s-1 as 3rd-line treatment for metastatic colorectal cancer in Japanese patients2014

    • Author(s)
      Yasunori Emi, Eiji Oki, Hiroshi Saeki, Hiroyuki Kitao, Hironori Samura, Takao Takahashi, Terumitsu Sawai, Yoshito Akagi, Akihito Tsuji, Susumu Eguchi, Kazuhiro Yoshida, Hideo Baba, Yutaka Ogata, Shoji Natsugoe, Mototugu Shimokawa, Yoshihiko Maehara
    • Organizer
      ASCO-GI
    • Place of Presentation
      San Francisco, USA
    • Related Report
      2013 Research-status Report
  • [Presentation] Significance and accurate of HER2 evaluation as a new biomarker in advanced gastric cancer.2013

    • Author(s)
      Kimura Y., Oki E., Otsu H., Tsuda Y., Kasagi Y., Hidaka G., Zaitsu Y., Yukaya T., Kawano H., Ando K., Ida S., Aishima S., Saeki H., Morita M., Kusumoto T., Maehara Y.
    • Organizer
      The 10th International Gastric Cancer Congress(IGCC 2013)
    • Place of Presentation
      Verona, Italy
    • Related Report
      2013 Research-status Report
  • [Presentation] Phase II study of docetaxel (DTX) and s-1 as neoadjuvant chemotherapy for potentially R0 advanced gastric cancer2013

    • Author(s)
      Yasunori Emi, Tetsuya Kusumoto, Hiroshi Matsuura, Mototsugu Shimokawa, Yoshihiro Kakeji, Hideo Baba, Yoshihiko Maehara
    • Organizer
      The 10th International Gastric Cancer Congress(IGCC 2013)
    • Place of Presentation
      Verona, Italy
    • Related Report
      2013 Research-status Report
  • [Remarks] 九州大学大学院 消化器・総合外科

    • URL

      http://www.kyu2geka.com/

    • Related Report
      2013 Research-status Report

URL: 

Published: 2014-07-25   Modified: 2019-07-29  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi